Because maintaining a robust ROS level is important for tumor cell survival and malignant phenotypic progression, we hypothesize that breast cancer cells have multiple mechanisms, including the HBXIP/Nrf2 feedback pathway, to resist excessive ROS production during ECM detachment. Here, LAMTOR5 is linked to breast carcinoma.